• Yoshiyuki Kakehi, Mikio Sugimoto, Rikiya Taoka, and committee for establishment of the evidenced-based clinical practice guideline for prostate cancer of the Japanese Urological Association.
• Department of Urology, Faculty of Medicine, Kagawa University, Kagawa, Japan.
• Int. J. Urol. 2017 Sep 1; 24 (9): 648-666.

AbstractThese guidelines cover a wide range of topics from prostate cancer epidemiology to palliative care. Questions arising in daily clinical practice have been extracted and formulated as clinical questions. In the 4 years since the previous edition, there have been major changes - for example, robot-assisted prostatectomy has rapidly come into widespread use, and new hormones and anticancer drugs have been developed for castration-resistant prostate cancer. In response to these developments, the number of fields included in this guideline was increased from 11 in the 2012 edition to 16, and the number of clinical questions was increased from 63 to 70. The number of papers identified in searches of the existing literature increased from 4662 in the first edition, published in 2006, to 10 490 in the 2012 edition. The number of references has reached 29 448 just during this review period, indicating the exponential increase in research on the topic of prostate cancer. Clinical answers have been prepared based on the latest evidence. Recommendation grades for the clinical answers were determined by radiologists, pathologists, and other specialists in addition to urologists in order to reflect the recent advances and diversity of prostate cancer treatment. Here, we present a short English version of the original guideline, and overview its key clinical issues.© 2017 The Japanese Urological Association.

29 keywords...

hide…